Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

INDUSTRY EXPERT ARTICLES

Medical Device News Magazine features byline articles from medical device and biotechnology industry experts (KOLs). Our experts share their views including what the future holds for the medical device industry, how devices can improve patient outcomes, functionality and more.

Cost Burdens in American Health Systems

Finding Hidden Cost Burdens in American Health Systems | By Jim McCoy, President of Clinical Asset Management, TRIMEDX

Health systems continue to face ongoing pressures to reduce costs while maintaining quality patient care. With the average operating margin for hospitals at 0.84%, health systems are searching for ways to more effectively manage operating and capital budgets. However, gaps in data often hinder health systems by hiding cost burdens throughout the organization. These hidden costs limit health systems to finding one-time-savings without lasting relief from industry-wide pressures.

Read More »
CAR T Cell Therapy

CAR T Cell Therapy Is Offering Life-lines to Cancer Patients, but Only to Those Who Can Afford It | By Dr. Brandon McNaughton, Chief Executive Officer and Co-Founder of Akadeum

The creation of CAR T cell therapy begins with collection of the patient’s blood and separation of the lymphocytes. These include T cells, B cells, and innate lymphoid cells, all of which are separated through apheresis (leukapheresis). It is this separation process which, if optimized, has the potential to revolutionize immunotherapy treatments for cancer patients.

Read More »
Eliane Schutte, Xeltis CEO

New Living Blood Vessels Created Through Restorative Devices Open Unthinkable Treatment Avenues | By Eliane Schutte, Xeltis CEO

The latest results from a clinical trial presented today at the VEITHsymposium in New York City demonstrate how new living blood vessels created through restorative medical devices have become reality and can open unthinkable treatment avenues for patients. Xeltis is developing cardiovascular devices, namely artificial vessels and valves, that gradually create living and long-lasting vessels made of patients’ own, new healthy tissue.

Read More »